Any negotiation for new industry agreements in Australia will be set against the backdrop of a highly complex global environment, including US demands for higher prices. For many Australian-based affiliates, the threshold question might focus on whether their global organisations will even allow them to support any negotiation not premised on higher prices.
The next negotiation was always going to be complicated, the new reality will make it more so
August 25, 2025 Latest NewsBioPharmaComment
Latest Video
New Stories
-
Sigma confirms interest in the acquisition of UK pharmacy chain Boots
June 10, 2026 - -
Island secures USAMRIID partnership to advance Galidesivir dose study for Marburg
June 10, 2026 - - Australian Biotech -
Cartherics secures Japanese patent to bolster cell therapy push
June 10, 2026 - - Australian Biotech -
GSK to buy Nuvalent in a major move to acquire rights to late stage lung cancer candidates
June 10, 2026 - - Latest News -
Australian company secures US fast track for CAR-T in blood cancers
June 10, 2026 - - Latest News -
Industry campaign highlights MFN risk to US jobs and the broader economy
June 10, 2026 - - Latest News -
New report highlights the potential health-system benefits of pharmacist prescribing
June 9, 2026 - - Latest News

